
|
-
 -
|
0101 | COMPLETE ® I-SET INGREDIENTS: LUTEIN; ZEAXANTHIN; BILBERRY (ANTHOCYANINS); BLACK CURRANT (ANTHOCYANINS); GRAPE SEED (OLIGOMERIC PROANTHOCYANIDINS); GINKGO BILOBA (FLAVONE GLYCOSIDES, TRITERPENES) APPLICATION: MYOPIA ● GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● DIABETIC RETINOPATHY AND RETINAL IMPAIRMENTS ● LENS OPACITIES ● UV-INDUCED OXIDATIVE STRESS ● ADAPTATION TO DARKNESS AND BETTER VISION IN LOW-LIGHT CONDITIONS - |

|
0102 | COMPLETE ® I-SET WITH VITAMINS, SELENIUM AND ZINC INGREDIENTS: LUTEIN; ZEAXANTHIN; BILBERRY (ANTHOCYANINS); BLACK CURRANT (ANTHOCYANINS); GRAPE SEED (OLIGOMERIC PROANTHOCYANIDINS); GINKGO BILOBA (FLAVONE GLYCOSIDES, TRITERPENES); VITAMINS A, B1, B2, B3, B5, B6, B7, B9, B12, C, E, D3, K1; SELENIUM (Se); ZINC (Zn); COPPER (Cu) APPLICATION: MYOPIA ● GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● DIABETIC RETINOPATHY AND RETINAL IMPAIRMENTS ● LENS OPACITIES ● UV-INDUCED OXIDATIVE STRESS ● ADAPTATION TO DARKNESS AND BETTER VISION IN LOW-LIGHT CONDITIONS - |
 |
0103 | COMPLETE ® I-SET FORTE INGREDIENTS: LUTEIN; ZEAXANTHIN; BILBERRY (ANTHOCYANINS); BLACK CURRANT (ANTHOCYANINS); GRAPE SEED (OLIGOMERIC PROANTHOCYANIDINS); GINKGO BILOBA (FLAVONE GLYCOSIDES, TRITERPENES) APPLICATION: MYOPIA ● GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● DIABETIC RETINOPATHY AND RETINAL IMPAIRMENTS ● LENS OPACITIES ● UV-INDUCED OXIDATIVE STRESS ● ADAPTATION TO DARKNESS AND BETTER VISION IN LOW-LIGHT CONDITIONS - |
 |
0104 | COMPLETE ® I-SET FORTE WITH VITAMINS, SELENIUM AND ZINC INGREDIENTS: LUTEIN; ZEAXANTHIN; BILBERRY (ANTHOCYANINS); BLACK CURRANT (ANTHOCYANINS); GRAPE SEED (OLIGOMERIC PROANTHOCYANIDINS); GINKGO BILOBA (FLAVONE GLYCOSIDES, TRITERPENES); VITAMINS A, B1, B2, B3, B5, B6, B7, B9, B12, C, E, D3, K1; SELENIUM (Se); ZINC (Zn); COPPER (Cu) APPLICATION: MYOPIA ● GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● DIABETIC RETINOPATHY AND RETINAL IMPAIRMENTS ● LENS OPACITIES ● UV-INDUCED OXIDATIVE STRESS ● ADAPTATION TO DARKNESS AND BETTER VISION IN LOW-LIGHT CONDITIONS - |
 -
|
0105 | COMPLETE ® MARIGOLD EXTRACT PLUS+ INGREDIENTS: LUTEIN; ZEAXANTHIN; GOJI (POLYSACCHARIDES), VITAMIN C APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES - |
 -
|
0106 | COMPLETE ® BILBERRY EXTRACT PLUS+ INGREDIENTS: BILBERRY (ANTHOCYANINS); GREEN TEA (POLYPHENOLS); VITAMIN C APPLICATION: GLAUCOMA ● CATARACT ● MACULAR DEGENERATION ● DIABETIC RETINOPATHY ● LENS OPACITIES ● OTHER COMMON EYE DISEASES - |
 -
|
0107 | COMPLETE ® BLACK CURRANT EXTRACT PLUS+ INGREDIENTS: BLACK CURRANT (ANTHOCYANINS); GREEN TEA (POLYPHENOLS); VITAMIN C APPLICATION: MYOPIA ● GLAUCOMA ● UV-INDUCED OXIDATIVE STRESS ● ADAPTATION TO DARKNESS AND BETTER VISION IN LOW-LIGHT CONDITIONS - |
 - |
0108 | COMPLETE ® VISINAL FORTE INGREDIENTS: LUTEIN; ZEAXANTHIN; ASTAXANTHIN; VITAMINS A, B1, B2, B3, B5, B6, B7, B9, B12, C, E, D3, K1; SELENIUM (Se); ZINC (Zn); COPPER (Cu) APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● NIGHT VISION ● LOSS OF VISION IN THE CENTRE OF VISUAL FIELD -- |
 - |
0109 | COMPLETE ® LUTEIN-10 INGREDIENTS: LUTEIN; ZEAXANTHIN APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES -- |
 - |
0110 | COMPLETE ® LUTEIN-20 INGREDIENTS: LUTEIN; ZEAXANTHIN APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES -- |
 - |
0111 | COMPLETE ® LUTEVIT INGREDIENTS: LUTEIN; ZEAXANTHIN; VITAMINS A, B1, B2, B3, B5, B6, B7, B9, B12, C, E, D3, K1 APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● NIGHT VISION ● LOSS OF VISION IN THE CENTRE OF VISUAL FIELD -- |
 - |
0112 | COMPLETE ® LUTEVIT FORTE INGREDIENTS: LUTEIN; ZEAXANTHIN; VITAMINS A, B1, B2, B3, B5, B6, B7, B9, B12, C, E, D3, K1 APPLICATION: GLAUCOMA ● CATARACT ● AGE-RELATED MACULAR DEGENERATION ● PIGMENTARY ABNORMALITIES ● NIGHT VISION ● LOSS OF VISION IN THE CENTRE OF VISUAL FIELD -- | - |